Low adoption of weight loss medications: A comparison of prescribing patterns of antiobesity pharmacotherapies and SGLT2s.
about
Off-label drugs for weight management.Aggressive clinical approach to obesity improves metabolic and clinical outcomes and can prevent bariatric surgery: a single center experienceAn Update on Naltrexone/Bupropion Extended-Release in the Treatment of Obesity.US health policy and prescription drug coverage of FDA-approved medications for the treatment of obesity.Single Fluid-Filled Intragastric Balloon Safe and Effective for Inducing Weight Loss in a Real-world Population.Low utilization of obesity medications: What are the implications for clinical care?
P2860
Low adoption of weight loss medications: A comparison of prescribing patterns of antiobesity pharmacotherapies and SGLT2s.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Low adoption of weight loss me ...... pharmacotherapies and SGLT2s.
@en
Low adoption of weight loss me ...... pharmacotherapies and SGLT2s.
@nl
type
label
Low adoption of weight loss me ...... pharmacotherapies and SGLT2s.
@en
Low adoption of weight loss me ...... pharmacotherapies and SGLT2s.
@nl
prefLabel
Low adoption of weight loss me ...... pharmacotherapies and SGLT2s.
@en
Low adoption of weight loss me ...... pharmacotherapies and SGLT2s.
@nl
P2093
P2860
P356
P1433
P1476
Low adoption of weight loss me ...... pharmacotherapies and SGLT2s.
@en
P2093
Alpana P Shukla
Elizabeth A Mauer
Louis J Aronne
Samrat Rathi
P2860
P304
P356
10.1002/OBY.21533
P577
2016-09-01T00:00:00Z